Clinical Trial: Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: A Phase 3, Multicenter, Double-Blind, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Hematogenous Osteomyel

Brief Summary: Dalbavancin for Pediatric Osteomyelitis